Narbasa, Alicia .
HRN: 28-68-54 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/10/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/10/2026
03/10/2026
IV
300mg
Q6
Cellulitis
Checking Initial Appropriateness
03/10/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/10/2026
03/16/2026
IV
4.5
Q8
Cellulitis
Checking Initial Appropriateness